134 related articles for article (PubMed ID: 29709714)
21. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
Smith SM; Coleman J; Bridge JA; Iwenofu OH
J Surg Oncol; 2015 Apr; 111(5):520-31. PubMed ID: 25772665
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
23. Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
Italiano A; Di Mauro I; Rapp J; Pierron G; Auger N; Alberti L; Chibon F; Escande F; Voegeli AC; Ghnassia JP; Keslair F; Laé M; Ranchère-Vince D; Terrier P; Baffert S; Coindre JM; Pedeutour F
Lancet Oncol; 2016 Apr; 17(4):532-538. PubMed ID: 26970672
[TBL] [Abstract][Full Text] [Related]
24. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.
Baheti AD; Jagannathan JP; O'Neill A; Tirumani H; Tirumani SH
Korean J Radiol; 2017; 18(1):94-106. PubMed ID: 28096721
[TBL] [Abstract][Full Text] [Related]
25. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
Mariño-Enríquez A; Bovée JV
Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
[TBL] [Abstract][Full Text] [Related]
26. Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers.
Sharma SR; Paonessa NE; Casadei L; Costas De Faria F; Pollock RE; Grignol V
J Surg Oncol; 2022 Feb; 125(2):239-245. PubMed ID: 34586640
[TBL] [Abstract][Full Text] [Related]
27. Soft tissue sarcomas: From a morphological to a molecular biological approach.
Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
[TBL] [Abstract][Full Text] [Related]
28. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas.
Barr FG; Chatten J; D'Cruz CM; Wilson AE; Nauta LE; Nycum LM; Biegel JA; Womer RB
JAMA; 1995 Feb; 273(7):553-7. PubMed ID: 7530783
[TBL] [Abstract][Full Text] [Related]
29. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
30. [Molecular Target Therapy for Soft Tissue Sarcoma].
Takahashi S
Gan To Kagaku Ryoho; 2017 Jun; 44(6):457-462. PubMed ID: 28698433
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared autofluorescence spectroscopy of in vivo soft tissue sarcomas.
Nguyen JQ; Gowani Z; O'Connor M; Pence I; Nguyen TQ; Holt G; Mahadevan-Jansen A
Opt Lett; 2015 Dec; 40(23):5498-501. PubMed ID: 26625035
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
33. [Sarcoma gene signatures].
Chibon F; Coindre JM
Pathologe; 2011 Feb; 32(1):32-9. PubMed ID: 21287318
[TBL] [Abstract][Full Text] [Related]
34. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
36. Perioperative outcome in sarcoma surgery.
Wente MN; Schwarzbach MH; Hinz U; Leowardi C; Mechtersheimer G; Krempien R; Egerer G; Friess H; Büchler MW
Langenbecks Arch Surg; 2007 Jan; 392(1):83-93. PubMed ID: 17131156
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
38. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
39. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
Kang S; Han I; Lee S; Kim W; Kim H
Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
